Why has the number of abortions not declined in France over the past 30 years?, 2004. ,
Réévaluation des contraceptifs oraux de 3ème génération, 2007. ,
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, BMJ, vol.343, pp.2001-2010, 2011. ,
Marion Larat lance l'alerte sur la pilule (Marion Larat launches the pill alert) Le Monde, 2012. ,
La crise de la pilule en France: vers un nouveau modèle contraceptif ? ,
Impact of media alerts on contraceptive pills medication, J Gynecol Obstet Biol Reprod, 2014. ,
La contraception en France: nouveau contexte, nouvelles pratiques ? ,
Etats des lieux des pratiques contraceptives et des freins à l'accès et au choix d'une contraception adaptée, 2013. ,
Comment diminuer le nombre des IVG en France ?, Gyn??cologie Obst??trique & Fertilit??, vol.31, issue.6, pp.499-503, 2003. ,
DOI : 10.1016/S1297-9589(03)00121-8
Tol??rance du dispositif intra-ut??rin au cuivre chez les patientes nullipares??: ??tude prospective unicentrique, Gyn??cologie Obst??trique & Fertilit??, vol.43, issue.2, pp.144-50, 2015. ,
DOI : 10.1016/j.gyobfe.2015.01.003
Estimates of unintended pregnancy rates over the last decade in France as a function of contraceptive behaviors, Contraception, vol.89, issue.4, pp.314-335, 2014. ,
DOI : 10.1016/j.contraception.2013.11.004
Trends and determinants of use of long-acting reversible contraception use among young women in France: results from three national surveys conducted between 2000 and 2010, Fertility and Sterility, vol.100, issue.2, pp.451-459, 2000. ,
DOI : 10.1016/j.fertnstert.2013.04.002
IUD use in France: women's and physician's perspectives, Contraception, vol.89, issue.1, pp.9-16, 2014. ,
DOI : 10.1016/j.contraception.2013.10.003
Use of Copper Intrauterine Devices and the Risk of Tubal Infertility among Nulligravid Women, New England Journal of Medicine, vol.345, issue.8, pp.561-568, 2001. ,
DOI : 10.1056/NEJMoa010438
Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review, Contraception, vol.73, issue.2, pp.145-53, 2006. ,
DOI : 10.1016/j.contraception.2005.08.007
Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers, Obstetrics & Gynecology, vol.121, issue.5, pp.951-959, 2013. ,
DOI : 10.1097/AOG.0b013e31828b63a0
Preventing Unintended Pregnancies by Providing No-Cost Contraception, Obstetrics & Gynecology, vol.120, issue.6, pp.1291-1298, 2012. ,
DOI : 10.1097/AOG.0b013e318273eb56
Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project, Contraception, vol.84, issue.5, pp.493-501, 2011. ,
DOI : 10.1016/j.contraception.2011.03.001
Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies, Journal of Thrombosis and Haemostasis, vol.9, issue.9, pp.1388-90, 2014. ,
DOI : 10.1111/jth.12661
Les IVG ont bel et bien augment?? en France en 2013, Gyn??cologie Obst??trique & Fertilit??, vol.43, issue.1, pp.1-2, 2015. ,
DOI : 10.1016/j.gyobfe.2014.11.010
Le nombre d'IVG est stable, mais moins de femmes y ont recours, Population, vol.69, issue.3, pp.365-398, 2014. ,
DOI : 10.3917/popu.1403.0365
Social consequences. The public health implications of the 1995 'pill scare', Human Reproduction Update, vol.5, issue.6, pp.621-627, 1999. ,
DOI : 10.1093/humupd/5.6.621
Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception, 5%) 94 (33.3%) 20 (7.1%) 113 (40.1%) 232 (82.3%) 50 (17.7%) 165 (58.7%) 49 (17.4%) 54 (19.2%)1%) 121 (41.9%) 105 (36.3%) 49 (17%) 51 (17.6%) 29 (10%) 55 (19%) 144 (49.8%) 44 (15.2%) 78 (13%) 186 (30.9%) 134) 57 (9.6%) 286 (48.4%) 515 (86.6%) 80 (13.4%) 304 (51.1%)6%) 98 (16.3%) 71 (11.8%) 87 (14.5%) 304 (50.6%), pp.121-158, 2011. ,
DOI : 10.1093/humupd/dmq026